Abstract
Editorial: Microbial Secondary Metabolites: Recent Developments and Technological Challenges.
Highlights
Microbial secondary metabolites, like antibiotics, pigments, growth hormones, antitumor agents, and others, are not essential for the growth and development of microorganism, but they have shown a great potential for human and animal health (Ruiz et al, 2010)
These bioactive compounds are mainly produced by the activation of cryptic gene clusters which are not active under normal conditions and, the expression of these clusters would be helpful in the exploitation of the chemical diversity of microorganisms (Pettit, 2011; Xu et al, 2019)
Several reports on microbial secondary metabolites have been published in recent years (Passari et al, 2017; Zothanpuia et al, 2018; Overy et al, 2019), our understanding to enhance the production of bioactive secondary metabolites is still limited
Summary
Like antibiotics, pigments, growth hormones, antitumor agents, and others, are not essential for the growth and development of microorganism, but they have shown a great potential for human and animal health (Ruiz et al, 2010). Microbial Secondary Metabolites: Recent Developments and Technological Challenges Among the microorganisms producing the above-mentioned compounds, bacteria, including actinobacteria, and fungi produce a diverse array of bioactive small molecules with significant potential to be used in medicine (O‘Brien and Wright, 2011).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.